Status:
UNKNOWN
Validation and Reliability of the CHO-KLAT in Turkish
Lead Sponsor:
Yuzuncu Yil University
Collaborating Sponsors:
Hasan Kalyoncu University
University of Gaziantep
Conditions:
Hemophilia A
Hemophilia B
Eligibility:
MALE
4-18 years
Phase:
NA
Brief Summary
The aim of this study is to investigate the Turkish validity and reliability of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool version2.0. Patients aged 4-18 years with hemophilia a or b...
Detailed Description
Health-related quality of life assessment is considered an important outcome in the evaluation of children with hemophilia. The Canadian Haemophilia Outcomes-Kids' Life Assessment Tool version2.0 is a...
Eligibility Criteria
Inclusion
- have Hemophilia A or B
Exclusion
- Did not have significant cognitive impairment
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05439642
Start Date
June 1 2022
End Date
December 1 2022
Last Update
June 30 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Adana Acibadem Hospital
Adana, Turkey (Türkiye)
2
Gaziantep University
Gaziantep, Turkey (Türkiye)
3
Hasan Kalyoncu University
Gaziantep, Turkey (Türkiye)
4
Van Yuzuncu Yıl University
Van, Turkey (Türkiye), 65100